THERAVANCE BIOPHARMA INC (TBPH)

KYG8807B1068 - Common Stock

9.47  -0.02 (-0.21%)

After market: 9.47 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
57.42M51.30M55.30M71.90M73.40M
Cost Of Goods
N/AN/AN/A0.000.00
Gross Profit
N/AN/AN/A71.90M73.40M
Operating Expenses
110.72M130.40M293.00M369.50M325.30M
Research and Development
40.62M63.40M192.30M260.20M219.10M
Selling, General, and Administrative Expenses
70.09M67.10M100.70M109.30M106.20M
Operating Income
-53.29M-79.10M-237.70M-297.60M-251.90M
Interest Income/Expense
6.77M2.20M-7.40M-4.10M10.20M
Other Income/Expense
N/A0.000.00-1.60MN/A
Non Recurring Items
-2.74M-15.90M-20.10M0.000.00
Income Before Taxes
-49.27M-92.80M-265.20M-303.30M-241.70M
Income Tax
5.92M0.00-200.00K-8.50M-5.20M
Net Income
-55.19M872.10M-199.40M-278.00M-236.50M
EBITDA
-51.29M-75.38M-231.79M-290.80M-245.46M
 
Per Share Data
EPS Diluted Total Ops
-1.0011.84-2.86-4.46-4.25
Non GAAP EPS
-0.97-0.67-2.95-4.48-4.26
 
Statistics
Gross Profit Margin
N/AN/AN/A100.00%100.00%
Profit Margin
-96.11%1700.00%-360.58%-386.65%-322.21%
Operating Profit Margin
-92.80%-154.19%-429.84%-413.91%-343.19%

All data in USD

Charts